Home  |  Contact

Cellosaurus SBC-3/ADM100 (CVCL_UW53)

[Text version]
Cell line name SBC-3/ADM100
Synonyms SBC-3/ADM 100
Accession CVCL_UW53
Resource Identification Initiative To cite this cell line use: SBC-3/ADM100 (RRID:CVCL_UW53)
Comments Population: Japanese.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_M841 (SBC-3/ADM)
Sex of cell Male
Age at sampling 24Y
Category Cancer cell line
Publications

PubMed=1442149; DOI=10.18926/AMO/32631
Takigawa N., Ohnoshi T., Ueoka H., Kiura K., Kimura I.
Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.
Acta Med. Okayama 46:249-256(1992)

PubMed=8104372; DOI=10.18926/AMO/31598
Kiura K., Ohnoshi T., Tabata M., Shibayama T., Kimura I.
Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.
Acta Med. Okayama 47:191-197(1993)

PubMed=9227790; DOI=10.18926/AMO/30795
Matsuo K., Kiura K., Ueoka H., Tabata M., Shibayama T., Matsumura T., Takigawa N., Hiraki S., Harada M.
Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
Acta Med. Okayama 51:121-127(1997)

Cross-references
Encyclopedic resources Wikidata; Q98129349
Entry history
Entry creation25-Feb-2019
Last entry update29-Jun-2023
Version number6